Posts by: Ana Pamplona, PhD

Hepatitis C, News

The daclatasvir-sofosbuvir regimen for the treatment of genotype 1 hepatitis C patients was granted amended Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA). In the beginning of 2015, ... Read more

April 27, 2015April 27, 2015

Direct Antiviral Agents Significantly Decreases Hepatitis C Recurrence After Liver Transplantation

Hepatitis C, News

During the 50th International Liver Congress 2015 held in Vienna 22-26 of April in Austria, it was revealed that sofosbuvir (SOF)- and daclatasvir (DCV)-based regimens showed excellent results in patients with ... Read more

March 19, 2015March 19, 2015

Combination of Ledipasvir and Sofosbuvir Adds Slight Therapeutic Benefit For HCV Infection

Hepatitis C, News

The German Institute for Quality and Efficiency in Health Care (IQWiG) is an independent scientific institute that analyzes the benefits and dangers of medical interventions for patients. Recently they examined the ... Read more

March 4, 2015March 5, 2015

Serum Identified as a Key Factor in Chronic HBV Interferon Therapy Effectiveness

Hepatitis B, News

A recent study identified high levels of interleukin (IL)-23 in patients’ serum as a biomarker for chronic hepatitis B patients positive for hepatitis B e antigen (HBeAg) responding to pegylated ... Read more

March 3, 2015March 3, 2015

HBV Patients With Nucleotide Analogue Resistance May Benefit from TDF Monotherapy

Hepatitis B, News

Recent research reports that tenofovir disoproxil fumarate (TDF) therapy for long periods is efficient in Chinese patients with chronic hepatitis B virus (HBV) infection that have relapsed after therapy with multiple ... Read more

February 23, 2015February 23, 2015

Hepatitis C Video by Canadian Gastrointestinal Society to Foster Infection Awareness

Hepatitis C, News

In Canada, hepatitis C affects at least 350,000 individuals — some of whom are not even aware of their infection and continue transmitting the virus. To call attention to this ... Read more

February 19, 2015February 19, 2015

Liver Cirrhosis Found More Prevalent Than Previous Estimates

Hepatitis C, News

A recent study evaluated the incidence of cirrhosis in the general American population. The study entitled “The Epidemiology of Cirrhosis in the United States: A Population-based Study” was published in ... Read more

February 17, 2015February 17, 2015

Study Reveals That Chemotherapy or Immunosuppressive Treatment May Reactivate HBV

Hepatitis B, News

A new review on the effect of Chemotherapy or immunosuppressive therapy in reactivation of Hepatitis B virus infection entitled “Recent US Food and Drug Administration warnings on hepatitis B reactivation ... Read more

February 13, 2015February 13, 2015

Study Reveals Hepatitis C Lacks Equal Attention Than HIV/AIDS or Ebola Yet is More Prevalent

Hepatitis B, Hepatitis C, News

A new study on Hepatitis C virus in West Africa entitled “High Frequency of Active HCV Infection Among Seropositive Cases in West Africa and Evidence for Multiple Transmission Pathways” was ... Read more

February 11, 2015February 13, 2015

AbbVie Reports Phase 3 Data on Ombitasvir-Paritaprevir-Ritonavir Therapy for Hepatitis C in Japan

Hepatitis C, News

AbbVie announced findings from a Phase 3 clinical trial (GIFT-I (M13-004)) for its new oral, ribavirin (RBV)-free antiviral treatment with a fixed-dose combination of paritaprevir/ritonavir (150/100 mg) with ombitasvir (25 mg), ... Read more